Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01685606 · ClinicalTrials.gov registry record · Phase 2
Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma
A Phase 2 study, sponsored by Brown University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT01685606 is a Phase 2 study that was terminated before completion, run by Brown University. The registered enrollment target is 6 participants.
The verdict
NCT01685606, a Phase 2 study, was terminated before completion, sponsored by Brown University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The study of whether an infusion of blood cells called lymphocytes from a donor can stimulate the immune system to fight your leukemia/lymphoma.
Interventions
- BIOLOGICAL cellular immunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01685606
The ClinicalTrials.gov registry entry for NCT01685606 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cellular immunotherapy is the first listed.
NCT01685606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01685606 about?
NCT01685606 is a clinical study titled "Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma". The study of whether an infusion of blood cells called lymphocytes from a donor can stimulate the immune system to fight your leukemia/lymphoma.
What is the current status of trial NCT01685606?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2013-03. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01685606?
The interventions under investigation include: cellular immunotherapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT01685606?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.